Ocugen, Inc. (OCGN)
0.7679
+0.04
(+4.79%)
USD |
NASDAQ |
Nov 20, 16:00
0.7679
0.00 (0.00%)
After-Hours: 20:00
Ocugen Shareholders Equity (Quarterly) : -17.68M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -17.68M |
| June 30, 2026 | -16.56M |
| March 31, 2026 | 5.805M |
| December 31, 2025 | -12.17M |
| September 30, 2025 | 3.533M |
| June 30, 2025 | 3.052M |
| March 31, 2025 | 15.91M |
| December 31, 2024 | 29.63M |
| September 30, 2024 | 40.63M |
| June 30, 2024 | 16.93M |
| March 31, 2024 | 30.26M |
| December 31, 2023 | 40.56M |
| September 30, 2023 | 58.40M |
| June 30, 2023 | 70.28M |
| March 31, 2023 | 75.80M |
| December 31, 2022 | 73.98M |
| September 30, 2022 | 95.30M |
| June 30, 2022 | 114.11M |
| March 31, 2022 | 131.13M |
| December 31, 2021 | 95.82M |
| September 30, 2021 | 107.11M |
| June 30, 2021 | 116.41M |
| March 31, 2021 | 46.49M |
| December 31, 2020 | 21.55M |
| September 30, 2020 | 14.42M |
| Date | Value |
|---|---|
| June 30, 2020 | 14.62M |
| March 31, 2020 | 7.297M |
| December 31, 2019 | 11.02M |
| September 30, 2019 | -13.09M |
| June 30, 2019 | -8.731M |
| March 31, 2019 | -5.532M |
| December 31, 2018 | -12.71M |
| September 30, 2018 | -9.676M |
| June 30, 2018 | -23.44M |
| March 31, 2018 | -20.07M |
| December 31, 2017 | -11.27M |
| September 30, 2017 | -4.813M |
| June 30, 2017 | 0.806M |
| March 31, 2017 | 6.972M |
| December 31, 2016 | 13.57M |
| September 30, 2016 | 4.036M |
| June 30, 2016 | 12.89M |
| March 31, 2016 | 20.59M |
| December 31, 2015 | 28.20M |
| September 30, 2015 | 36.18M |
| June 30, 2015 | 43.86M |
| March 31, 2015 | 51.22M |
| December 31, 2014 | 54.21M |
| September 30, 2014 | -31.45M |
| June 30, 2014 | -19.70M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.58M |
| Nektar Therapeutics | 849.72M |
| Heron Therapeutics, Inc. | 4.916M |
| TG Therapeutics, Inc. | 572.13M |
| Tonix Pharmaceuticals Holding Corp. | 199.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.06M |
| Total Liabilities (Quarterly) | 125.74M |
| Debt to Equity Ratio | -5.009 |
| Current Ratio | 0.7689 |
| Net Debt Paydown Yield | -3.19% |